Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Ilda Bidollari"'
Autor:
Jason Gotlib, Mariana Castells, Hanneke Oude Elberink, Frank Siebenhaar, Karin Hartmann, Sigurd Broesby-Olsen, Tracy I. George, Jens Panse, Ivan Alvarez-Twose, Deepti Radia, Tsewang Tashi, Cristina Bulai Livideanu, Vito Sabato, Paul Van Daele, Sonia Cerquozzi, Ingunn Dybedal, Andreas Reiter, Celalettin Ustun, Philippe Schafhausen, Prithviraj Bose, Daniel J. Deangelo, Lindsay Rein, Pankit Vachhani, Massimo Triggiani, Mark Rafferty, Nauman Butt, Stephen Oh, Friederike Wortmann, Johanna Ungerstedt, Minakshi Taparia, Andrew T. Kuykendall, Cecilia Arana Yi, Mattias Mattsson, William Shomali, Matthew Giannetti, Ilda Bidollari, Hui-Min Lin, Robyn Scherber, Maria Roche, Cem Akin, Marcus Maurer
Publikováno v:
HemaSphere, Vol 7, p e7796003 (2023)
Externí odkaz:
https://doaj.org/article/060bc67958084d12a5551ad176dad26a
Autor:
Yan Wang, John Powderly, Marc Ernstoff, Anthony Shields, Ulka Vaishampayan, John Wrangle, Sarina Piha-Paul, Anthony Olszanski, Lei Sun, Bradley Carthon, Kelly Curtis, Ilda Bidollari, Yangchun Du, Emily Putiri, Heather Losey, Bruce Dezube
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/1ad3ff19fadb4798b39071e0dee24631
Autor:
Jason Gotlib, Mariana Castells, Hanneke Oude Elberink, Frank Siebenhaar, Karin Hartmann, Sigurd Broesby-Olsen, Tracy I. George, Jens Panse, Iván Alvarez-Twose, Deepti H. Radia, Tsewang Tashi, Cristina Bulai Livideanu, Vito Sabato, Mark Heaney, Paul Van Daele, Sonia Cerquozzi, Ingunn Dybedal, Andreas Reiter, Thanai Pongdee, Stéphane Barete, Celalettin Ustun, Lawrence Schwartz, Brant R. Ward, Philippe Schafhausen, Peter Vadas, Prithviraj Bose, Daniel J. DeAngelo, Lindsay Rein, Pankit Vachhani, Massimo Triggiani, Patrizia Bonadonna, Mark Rafferty, Nauman M. Butt, Stephen T. Oh, Friederike Wortmann, Johanna Ungerstedt, Mar Guilarte, Minakshi Taparia, Andrew T. Kuykendall, Cecilia Arana Yi, Princess Ogbogu, Caroline Gaudy-Marqueste, Mattias Mattsson, William Shomali, Matthew P. Giannetti, Ilda Bidollari, Hui-Min Lin, Erin Sulllivan, Brenton Mar, Robyn Scherber, Maria Roche, Cem Akin, Marcus Maurer
Publikováno v:
NEJM Evidence. 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::76fc829d6aa73bbc3d731e9ea9fff822
https://doi.org/10.1056/evidoa2200339
https://doi.org/10.1056/evidoa2200339
Autor:
Deepti H. Radia, Jason Gotlib, Mark W. Drummond, Tracy I. George, Hui-Min Lin, Saša Dimitrijević, Javier I. Munoz-Gonzalez, Ilda Bidollari, Michael W. Deininger, Daniel J. DeAngelo, Andreas Reiter
Publikováno v:
Blood. 140:1509-1511
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::877c32faae4a7a28f4e6b31efe586dd2
https://doi.org/10.1182/blood-2022-166986
https://doi.org/10.1182/blood-2022-166986
Autor:
Daniel J. DeAngelo, Deepti H. Radia, Tracy I. George, William A. Robinson, Albert T. Quiery, Mark W. Drummond, Prithviraj Bose, Elizabeth O. Hexner, Elliott Winton, Hans-Peter Horny, Meera Tugnait, Hui-Min Lin, Saša Dimitrijević, Javier I. Munoz-Gonzalez, Ilda Bidollari, Michael W. Deininger, Jason Gotlib
Publikováno v:
Blood. 140:3932-3934
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3b35842025a9abe675ca052303fde0d6
https://doi.org/10.1182/blood-2022-167593
https://doi.org/10.1182/blood-2022-167593
Autor:
Robert T. Naismith, Elzbieta Jasinska, Hailu Chen, Jennifer L. Lyons, Maria Lopez-Bresnahan, Annette Wundes, Tjalf Ziemssen, David Rezendes, Jerry S. Wolinsky, Anthony Lembo, Richard Leigh-Pemberton, Krzysztof Selmaj, Catherine Miller, Ilda Bidollari, Jerome Hanna, Mark S. Freedman
Publikováno v:
CNS Drugs
Background Diroximel fumarate (DRF) is a novel oral fumarate approved in the USA for relapsing forms of multiple sclerosis. DRF is converted to monomethyl fumarate, the pharmacologically active metabolite of dimethyl fumarate (DMF). DRF 462 mg and DM
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca8913e2f749d7400243f5d2ebf08015
http://europepmc.org/articles/PMC7018784
http://europepmc.org/articles/PMC7018784
Autor:
Mariana Castells, Jason Gotlib, Hanneke Oude Elberink, Frank Siebenhaar, Karin Hartmann, Sigurd Broesby-Olsen, Tracy George, Jens Panse, Ivan Alvarez-Twose, Deepti Radia, Tsewang Tashi, Cristina Bulai Livideanu, Vito Sabato, Paul Van Daele, Sonia Cerquozzi, Ingunn Dybedal, Andreas Reiter, Thanai Pongdee, Stéphane Barete, Lawrence Schwartz, Prithviraj Bose, Massimo Triggiani, William Shomali, Matthew Giannetti, Ilda Bidollari, Hui-Min Lin, Robyn Scherber, Maria Roche, Cem Akin, Marcus Maurer
Publikováno v:
Journal of Allergy and Clinical Immunology. 151:AB204
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::76832b7416f2e44ddef5487ea1ab0f33
https://doi.org/10.1016/j.jaci.2022.12.635
https://doi.org/10.1016/j.jaci.2022.12.635
Autor:
Lili Yang, Hailu Chen, Douglas L. Arnold, Catherine Miller, David Rezendes, Boris Kandinov, Christopher LaGanke, Jerry S. Wolinsky, Mark S. Freedman, Maria Lopez-Bresnahan, Narinder Nangia, Dragana Obradovic, Jerome Hanna, Tjalf Ziemssen, Annette Wundes, Robert T. Naismith, Richard Leigh-Pemberton, Ilda Bidollari, Mark Gudesblatt, Shifang Liu
Publikováno v:
Multiple Sclerosis (Houndmills, Basingstoke, England)
Background: Diroximel fumarate (DRF) is a novel oral fumarate for patients with relapsing–remitting multiple sclerosis (RRMS). DRF and the approved drug dimethyl fumarate yield bioequivalent exposure to the active metabolite monomethyl fumarate; th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e640589855d107759e6c8b6cdb11ba81
http://europepmc.org/articles/PMC7604551
http://europepmc.org/articles/PMC7604551
Autor:
John Powderly, Bradley Carthon, Marc Ernstoff, Anthony Olszanski, John Wrangle, Anthony Shields, Sarina Piha-Paul, Kelly Curtis, Ilda Bidollari, Yangchun Du, Lei Sun, Emily Putiri, Yan Wang, Heather Losey, Bruce Dezube, Ulka Vaishampayan
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Background ALKS 4230 is a novel engineered cytokine designed to selectively bind and activate the intermediate affinity IL-2 receptor. Intravenous (IV) dosing of ALKS 4230 has shown encouraging efficacy and acceptable tolerability, as monotherapy and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be59d8e703ebaa05caaf1585a113fc8e
https://doaj.org/article/1ad3ff19fadb4798b39071e0dee24631
https://doaj.org/article/1ad3ff19fadb4798b39071e0dee24631
Autor:
Christopher J. Hoimes, Ulka N. Vaishampayan, Olivier Dumas, Valentina Boni, Marc S. Ernstoff, Yangchun Du, Anna Spreafico, Aman Chauhan, Arvind Chaudhry, Vamsidhar Velcheti, Ira Winer, Lucy Gilbert, Heather C. Losey, Ilda Bidollari, Jessicca Martin Rege, Jameel Muzaffar, Bruce Dezube, Quincy Chu, Piotr Tomczak, Seth David Rosen, Kelly Curtis, David F. McDermott, Elizabeth Dorn, Lei Sun, Yan Wang, James Strauss, Debora S. Bruno, Emily Putiri
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Background ALKS 4230 is a novel engineered cytokine that selectively targets the intermediate-affinity interleukin-2 receptor complex to activate CD8+ T cells and natural killer cells.1 The ARTISTRY-1 trial (NCT02799095) has shown encouraging efficac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b92d9321692e6159eed965d5d8bb793c
https://doaj.org/article/5558dc32bb3f46a4a9c1044cc2c6eec4
https://doaj.org/article/5558dc32bb3f46a4a9c1044cc2c6eec4